Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children
NCT ID: NCT00446628
Last Updated: 2016-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3360 participants
INTERVENTIONAL
2007-01-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REDucing Influenza Among University Students, University of California at Berkeley
NCT00448773
From Innovation to Solutions: Childhood Influenza Vaccination Planning
NCT01664793
A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households
NCT00425893
Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission
NCT00490633
Household Influenza Transmission Study
NCT01251679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Phase 1 of the project will be a pilot study in two elementary schools in the City of Pittsburgh. The project has already obtained agreement to collaborate from the Pittsburgh Public School System and we have assembled a multi-disciplinary team of epidemiologists, systems analysts, modelers, community and minority health workers, and virologists to implement the project. Phase one was in 2 schools.
Phase 2 will be similar to Phase 1 with the addition of additional schools and application of a "hygiene" intervention to selected schools and families. Phase 2 is in 10 schools with 3800 students.
Specific aims (year 02):
Primary
1. Measure the effectiveness of non-pharmaceutical interventions (NPIs) in reducing influenza rates among enrolled students in the intervention and control schools when influenza is known to be circulating in the community. \[Note: Enrolled, for purposes of PIPP, will indicate students who present with ILI, consent to participate, and are tested for influenza during the flu season.\] Secondary: School-Based
2. Measure number of absentees and determine the reason for absence by using a school based absentee illness surveillance system prior to and through the end of influenza season.
3. Measure the effectiveness of NPIs in reducing absenteeism from all causes, including illness/URI, illness/ILI, illness/other, and illness/GI through the end of influenza season.
4. Measure the effectiveness of NPIs in reducing secondary spread of ILI within classrooms of participating schools.
5. Assess adoption of NPI behaviors and activities in classrooms of intervention schools.
Secondary: Home-Based
6. Measure the effectiveness of NPIs in reducing secondary cases of ILI within families of enrolled school children with influenza.
7. Assess adherence of families of enrolled school children with influenza to isolation-related NPI behaviors and activities.
Tertiary
8. Measure correlation between rapid flu testing and PCR testing for influenza.
9. Collect and archive influenza specimens for future molecular epidemiological studies.
10. Contribute a sample of influenza-positive specimens to the CDC for national influenza surveillance purposes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
Five elementary school received intervention consistin of training in hand and respiratory hygiene, and access to hand sanitizer
behaviors reducing spread of influenza
Non-pharmaceutical interventions for flu prevention
control
Five elementary school received no training or hand sanitizer.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
behaviors reducing spread of influenza
Non-pharmaceutical interventions for flu prevention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parental consent and student assent.
* Shares living space with K-8 child who has current influenza infection.
* Parental consent and child assent in the case of minors.
* Individual consent if over the age of 18.
* Will continue in the study even if student with confirmed influenza withdraws from the study.
Exclusion Criteria
* The participant is unable to tolerate a swab or capillary finger stick.
* There is a delay in notification or testing such that symptoms have resolved.
* The participant has a medical or mental health condition which in the judgment of the investigator is a barrier to safe participation.
* The participant is younger than 6 months.
* The participant is unable to tolerate a swab or capillary finger stick.
6 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kiren Mitruka
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kiren Mitruka
Medical officer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald S Burke, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Sam Stebbins, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh School of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDC-U01 CI000435-01
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CDC-NCPDCID-CC-0612047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.